# Filing Detail

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001636282-24-000107
Filing Date
2024-11-18
Accepted
2024-11-18 16:03:42
Documents
108
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | syre-20231231.htm iXBRL | 10-K/A | 1519228
2 | EX-23.1 | ex231spyre2023formconsent1.htm | EX-23.1 | 2365
3 | EX-31.1 | spyre-20241231xex311a.htm | EX-31.1 | 9604
4 | EX-31.2 | spyre-20241231xex312a.htm | EX-31.2 | 9613
5 | EX-32.1 | spyre-20241231xex321a.htm | EX-32.1 | 6309
| Complete submission text file | 0001636282-24-000107.txt |  | 10779209

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | syre-20231231.xsd | EX-101.SCH | 86887
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | syre-20231231_cal.xml | EX-101.CAL | 95106
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | syre-20231231_def.xml | EX-101.DEF | 577132
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | syre-20231231_lab.xml | EX-101.LAB | 928738
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | syre-20231231_pre.xml | EX-101.PRE | 752056
111 | EXTRACTED XBRL INSTANCE DOCUMENT | syre-20231231_htm.xml | XML | 1603158

Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37722 | Film No.: 241471431
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)